C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 211/72 (2006.01) A61K 31/4168 (2006.01) C07D 207/22 (2006.01) C07D 239/14 (2006.01) C07D 243/04 (2006.01) C07D 295/08 (2006.01) C07D 401/12 (2006.01) C07D 405/12 (2006.01)
Patent
CA 2530538
Methods for treatment of IP antagonist mediated diseases or conditions by administration to a subject in need thereof a compound of formula (I) wherein R1, R 2 , A and X are as defined herein. Also disclosed are compounds and related compositions.
L'invention concerne des procédés de traitement de maladies ou d'états médiés par l'antagoniste IP, qui consistent à administrer au patient nécessitant ce traitement un composé de la formule (I), dans laquelle R?1¿, R?2¿, A et X sont tels que définis dans le descriptif. L'invention concerne également des composés et des compositions connexes.
Bley Keith Roger
Clark Robin Douglas
Jahangir Alam
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Thiophenylaminoimidazolines as prostaglandin i2 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiophenylaminoimidazolines as prostaglandin i2 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiophenylaminoimidazolines as prostaglandin i2 antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1656125